Cracking the code for cerebellar movement disorders

byTexas Children's HospitalSupervised classifier model predicts mouse phenotype based on spike signatures. Credit:eLife(2024). DOI: 10.7554/eLife.91483.2The cerebellum is a regio

Updated on: July 05,2024

Cracking the code for cerebellar movement disorders

byTexas Children's HospitalSupervised classifier model predicts mouse phenotype based on spike signatures. Credit:eLife(2024). DOI: 10.7554/eLife.91483.2The cerebellum is a regio

Updated on:July 05,2024

A participatory research project tackling Alzheimer's disease

by Egle Marija Ramanauskaite,Public Library of ScienceCredit: Human Computation Institute CC-BY-NC-SA 4.0, Graphic by PachecoDesignlab.comEarlier this year, weintroducedyou to WeCure

Updated on: February 28,2024

A participatory research project tackling Alzheimer's disease

by Egle Marija Ramanauskaite,Public Library of ScienceCredit: Human Computation Institute CC-BY-NC-SA 4.0, Graphic by PachecoDesignlab.comEarlier this year, weintroducedyou to WeCure

Updated on:February 28,2024

Researchers determine how the hippocampus generates and sustains oscillations

byRIKENA fluorescence micrograph of a CA1 in a mouse’s hippocampus. RIKEN researchers silenced the pyramidal cells in this region. Credit: Adapted fromNature Communications(2024). DO

Updated on: August 08,2024

Researchers determine how the hippocampus generates and sustains oscillations

byRIKENA fluorescence micrograph of a CA1 in a mouse’s hippocampus. RIKEN researchers silenced the pyramidal cells in this region. Credit: Adapted fromNature Communications(2024). DO

Updated on:August 08,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

Summit to tackle tricky problems of aging and dementia

by Kara Manke,University of California - BerkeleyThe second annual Aging, Research, and Technology Innovation Summit on Tuesday will gather researchers, entrepreneurs, policymakers, and health c

Updated on: July 01,2024

Summit to tackle tricky problems of aging and dementia

by Kara Manke,University of California - BerkeleyThe second annual Aging, Research, and Technology Innovation Summit on Tuesday will gather researchers, entrepreneurs, policymakers, and health c

Updated on:July 01,2024

BMI1, a promising gene to protect against Alzheimer's disease

by Julie Gazaille,University of MontrealHealthy neurons (left) and Alzheimer's disease neurons (right): in green, accumulation of G4 structures in Alzheimer’s neurons. Credit: University of

Updated on: March 19,2024

BMI1, a promising gene to protect against Alzheimer's disease

by Julie Gazaille,University of MontrealHealthy neurons (left) and Alzheimer's disease neurons (right): in green, accumulation of G4 structures in Alzheimer’s neurons. Credit: University of

Updated on:March 19,2024

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on: April 20,2024

Potential new biomarker for Alzheimer's discovered

by Max Delbrück Center for Molecular MedicineThe Arl8b protein (turquoise) shows an accumulation around the amyloid-b aggregates (red). Cell nuclei are stained blue. The section was analyzed with

Updated on:April 20,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on: March 09,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on:March 09,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on: February 28,2024

Homocysteine tied to Alzheimer's via A-beta-fibrinogen interaction

(HealthDay)—Plasma homocysteine (HC) and its metabolite homocysteine thiolactone (HCTL) contribute to Alzheimer's disease (AD) pathology via the amyloid-β (Aβ)-fibrinogen interaction, according to

Updated on:February 28,2024

New project focuses on dementia in farming and rural communities

by Andrew Gould,University of PlymouthDementia is a growing health problem, with an anticipated increase in the number of cases of 156 per cent between now and 2051, according to statistics from

Updated on: February 28,2024

New project focuses on dementia in farming and rural communities

by Andrew Gould,University of PlymouthDementia is a growing health problem, with an anticipated increase in the number of cases of 156 per cent between now and 2051, according to statistics from

Updated on:February 28,2024

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet

Updated on: March 07,2024

Possible pathway to new therapy for Alzheimer's disease

by Boston University School of MedicineResearchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of bet

Updated on:March 07,2024

Researchers use MRI to predict Alzheimer's disease

by Radiological Society of North AmericaAreas of reduced fractional anisotropy -- a diffusion MR imaging marker of white matter damage -- in 20 persons who develop Alzheimer's dementia compar

Updated on: March 09,2024

Researchers use MRI to predict Alzheimer's disease

by Radiological Society of North AmericaAreas of reduced fractional anisotropy -- a diffusion MR imaging marker of white matter damage -- in 20 persons who develop Alzheimer's dementia compar

Updated on:March 09,2024